Literature DB >> 26372505

A Phenotypic Screen for Functional Mutants of Human Adenosine Deaminase Acting on RNA 1.

Yuru Wang1, Jocelyn Havel1, Peter A Beal1.   

Abstract

Adenosine deaminases acting on RNA (ADARs) are RNA-editing enzymes responsible for the conversion of adenosine to inosine at specific locations in cellular RNAs. ADAR1 and ADAR2 are two members of the family that have been shown to be catalytically active. Earlier, we reported a phenotypic screen for the study of human ADAR2 using budding yeast S. cerevisiae as the host system. While this screen has been successfully applied to the study of ADAR2, it failed with ADAR1. Here, we report a new reporter that uses a novel editing substrate and is suitable for the study of ADAR1. We screened plasmid libraries with randomized codons for two important residues in human ADAR1 (G1007 and E1008). The screening results combined with in vitro deamination assays led to the identification of mutants that are more active than the wild type protein. Furthermore, a screen of the ADAR1 E1008X library with a reporter construct bearing an A•G mismatch at the editing site suggests one role for the residue at position 1008 is to sense the identity of the base pairing partner for the editing site adenosine. This work has provided a starting point for future in vitro evolution studies of ADAR1 and led to new insight into ADAR's editing site selectivity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26372505      PMCID: PMC4900682          DOI: 10.1021/acschembio.5b00711

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  31 in total

1.  Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2.

Authors:  M Higuchi; S Maas; F N Single; J Hartner; A Rozov; N Burnashev; D Feldmeyer; R Sprengel; P H Seeburg
Journal:  Nature       Date:  2000-07-06       Impact factor: 49.962

2.  A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains.

Authors:  C X Chen; D S Cho; Q Wang; F Lai; K C Carter; K Nishikura
Journal:  RNA       Date:  2000-05       Impact factor: 4.942

3.  Matching active site and substrate structures for an RNA editing reaction.

Authors:  Subhash Pokharel; Prasanna Jayalath; Olena Maydanovych; Rena A Goodman; Selina C Wang; Dean J Tantillo; Peter A Beal
Journal:  J Am Chem Soc       Date:  2009-08-26       Impact factor: 15.419

4.  Dystonia, mental deterioration, and dyschromatosis symmetrica hereditaria in a family with ADAR1 mutation.

Authors:  Kana Tojo; Yoshiki Sekijima; Tamio Suzuki; Noriyuki Suzuki; Yasushi Tomita; Kunihiro Yoshida; Takao Hashimoto; Shu-Ichi Ikeda
Journal:  Mov Disord       Date:  2006-09       Impact factor: 10.338

5.  RNA-Seq analysis identifies a novel set of editing substrates for human ADAR2 present in Saccharomyces cerevisiae.

Authors:  Tristan Eifler; Subhash Pokharel; Peter A Beal
Journal:  Biochemistry       Date:  2013-10-31       Impact factor: 3.162

6.  Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities.

Authors:  K A Lehmann; B L Bass
Journal:  Biochemistry       Date:  2000-10-24       Impact factor: 3.162

7.  A mammalian reporter system for fast and quantitative detection of intracellular A-to-I RNA editing levels.

Authors:  Willemijn M Gommans; Jill McCane; Gregory S Nacarelli; Stefan Maas
Journal:  Anal Biochem       Date:  2010-01-04       Impact factor: 3.365

8.  ADAR2 A-->I editing: site selectivity and editing efficiency are separate events.

Authors:  Annika M Källman; Margareta Sahlin; Marie Ohman
Journal:  Nucleic Acids Res       Date:  2003-08-15       Impact factor: 16.971

9.  Predicting sites of ADAR editing in double-stranded RNA.

Authors:  Julie M Eggington; Tom Greene; Brenda L Bass
Journal:  Nat Commun       Date:  2011       Impact factor: 14.919

10.  The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.

Authors:  Niamh M Mannion; Sam M Greenwood; Robert Young; Sarah Cox; James Brindle; David Read; Christoffer Nellåker; Cornelia Vesely; Chris P Ponting; Paul J McLaughlin; Michael F Jantsch; Julia Dorin; Ian R Adams; A D J Scadden; Marie Ohman; Liam P Keegan; Mary A O'Connell
Journal:  Cell Rep       Date:  2014-11-13       Impact factor: 9.423

View more
  11 in total

1.  RNA binding candidates for human ADAR3 from substrates of a gain of function mutant expressed in neuronal cells.

Authors:  Yuru Wang; Dong Hee Chung; Leanna R Monteleone; Jie Li; Yao Chiang; Michael D Toney; Peter A Beal
Journal:  Nucleic Acids Res       Date:  2019-11-18       Impact factor: 16.971

2.  DNA editing in DNA/RNA hybrids by adenosine deaminases that act on RNA.

Authors:  Yuxuan Zheng; Claire Lorenzo; Peter A Beal
Journal:  Nucleic Acids Res       Date:  2017-04-07       Impact factor: 16.971

3.  Selective Recognition of RNA Substrates by ADAR Deaminase Domains.

Authors:  Yuru Wang; SeHee Park; Peter A Beal
Journal:  Biochemistry       Date:  2018-02-21       Impact factor: 3.162

4.  Probing RNA recognition by human ADAR2 using a high-throughput mutagenesis method.

Authors:  Yuru Wang; Peter A Beal
Journal:  Nucleic Acids Res       Date:  2016-09-09       Impact factor: 16.971

5.  RNA editing with CRISPR-Cas13.

Authors:  David B T Cox; Jonathan S Gootenberg; Omar O Abudayyeh; Brian Franklin; Max J Kellner; Julia Joung; Feng Zhang
Journal:  Science       Date:  2017-10-25       Impact factor: 47.728

6.  Rational Design of RNA Editing Guide Strands: Cytidine Analogs at the Orphan Position.

Authors:  Erin E Doherty; Xander E Wilcox; Lenka van Sint Fiet; Cherie Kemmel; Janne J Turunen; Bart Klein; Dean J Tantillo; Andrew J Fisher; Peter A Beal
Journal:  J Am Chem Soc       Date:  2021-05-03       Impact factor: 15.419

Review 7.  Base editing: advances and therapeutic opportunities.

Authors:  Elizabeth M Porto; Alexis C Komor; Ian M Slaymaker; Gene W Yeo
Journal:  Nat Rev Drug Discov       Date:  2020-10-19       Impact factor: 112.288

8.  Mechanistic implications of enhanced editing by a HyperTRIBE RNA-binding protein.

Authors:  Weijin Xu; Reazur Rahman; Michael Rosbash
Journal:  RNA       Date:  2017-11-10       Impact factor: 4.942

Review 9.  RNA editing as a therapeutic approach for retinal gene therapy requiring long coding sequences.

Authors:  Lewis E Fry; Caroline F Peddle; Alun R Barnard; Michelle E McClements; Robert E MacLaren
Journal:  Int J Mol Sci       Date:  2020-01-25       Impact factor: 5.923

10.  Regulation of RNA editing by intracellular acidification.

Authors:  Turnee N Malik; Erin E Doherty; Vandana M Gaded; Theodore M Hill; Peter A Beal; Ronald B Emeson
Journal:  Nucleic Acids Res       Date:  2021-04-19       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.